HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weiguo Cui Selected Research

vapiprost

1/2021Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weiguo Cui Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 01/2014
11Infections
01/2022 - 08/2007
5Virus Diseases (Viral Diseases)
01/2022 - 09/2010
4Inflammation (Inflammations)
12/2019 - 08/2007
3Leukemia
01/2021 - 11/2011
3Persistent Infection
12/2019 - 11/2018
2Thrombosis (Thrombus)
04/2021 - 01/2021
1Neoplasm Metastasis (Metastasis)
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2021
1Sickle Cell Anemia (Hemoglobin S Disease)
06/2021
1Thrombocytopenia (Thrombopenia)
04/2021
1COVID-19
04/2021
1Carcinogenesis
01/2021
1Human Influenza (Influenza)
01/2021
1Viral Pneumonia
01/2021
1Hemorrhage
01/2021
1Melanoma (Melanoma, Malignant)
01/2020
1Hemophilia A (Haemophilia)
10/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2019
1Lymphoma (Lymphomas)
10/2017
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2017
1Coinfection
05/2014
1Experimental Melanoma
01/2014
1Blast Crisis (Blast Phase)
11/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2011
1Dengue (Dengue Fever)
09/2010
1Listeriosis (Listeria Infection)
03/2009

Drug/Important Bio-Agent (IBA)

5interleukin-21 (interleukin 21)IBA
01/2022 - 11/2015
5RNA (Ribonucleic Acid)IBA
01/2021 - 11/2018
5AntigensIBA
01/2020 - 03/2009
4Phosphotransferases (Kinase)IBA
01/2021 - 10/2017
4Antiviral Agents (Antivirals)IBA
12/2019 - 08/2014
3CytokinesIBA
01/2022 - 03/2009
3AntibodiesIBA
04/2021 - 01/2019
3Transcription Factors (Transcription Factor)IBA
03/2021 - 11/2015
3CateninsIBA
01/2021 - 01/2014
3Interleukin-10 (Interleukin 10)IBA
11/2018 - 08/2014
2Small Cytoplasmic RNAIBA
01/2022 - 01/2021
2Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 12/2019
2VaccinesIBA
01/2021 - 09/2010
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2018 - 01/2017
2Interleukin-12 (IL 12)IBA
10/2011 - 03/2009
2Interleukin-7 (Interleukin 7)IBA
09/2010 - 08/2007
1PF-543IBA
01/2022
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022
1SphingosineIBA
01/2022
1Insulin (Novolin)FDA Link
10/2021
1Hydroxyurea (Hydrea)FDA LinkGeneric
06/2021
1Antineoplastic Agents (Antineoplastics)IBA
06/2021
1Pharmaceutical PreparationsIBA
06/2021
1Heparin (Liquaemin)FDA LinkGeneric
04/2021
1Immunoglobulins (Immunoglobulin)IBA
04/2021
1Platelet Factor 4IBA
04/2021
1InterleukinsIBA
03/2021
1vapiprostIBA
01/2021
1AZD1208IBA
01/2021
1CarcinogensIBA
01/2021
1Immune Checkpoint ProteinsIBA
01/2021
1Cyclooxygenase InhibitorsIBA
01/2021
1Protein Subunit VaccinesIBA
01/2021
1Prostaglandin H2 Thromboxane A2 ReceptorsIBA
01/2021
1proto-oncogene proteins pimIBA
01/2021
1Indomethacin (Indometacin)FDA LinkGeneric
01/2021
1Pyruvic Acid (Pyruvate)IBA
10/2020
1duroquinol (durohydroquinone)IBA
10/2020
1malic acid (malate)IBA
10/2020
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
10/2020
1triphenylphosphoniumIBA
10/2020
1oxidized low density lipoproteinIBA
12/2019
1Proteins (Proteins, Gene)FDA Link
10/2019
1Viral AntigensIBA
01/2019
1AutoantibodiesIBA
01/2019
1AutoantigensIBA
01/2019
1Platelet Endothelial Cell Adhesion Molecule-1IBA
11/2018
1Diacylglycerol KinaseIBA
04/2018
1Protein Kinases (Protein Kinase)IBA
10/2017
1Bacterial AntigensIBA
01/2017
1Cancer VaccinesIBA
01/2017
1Ouabain (G Strophanthin)IBA
01/2017
1Cardiac GlycosidesIBA
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2016
1Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA
12/2015
1LigandsIBA
05/2014
1monophosphoryl lipid AIBA
05/2014
1Neoplasm Antigens (Tumor Antigens)IBA
01/2014
1Minor Histocompatibility AntigensIBA
11/2011
116-iodo-3-methylhexadecanoic acid (MIHA)IBA
11/2011
1Interleukin-15 (Interleukin 15)IBA
09/2010
1T-box transcription factor TBX21IBA
08/2007

Therapy/Procedure

9Immunotherapy
01/2022 - 01/2017
4Therapeutics
01/2022 - 01/2017
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2020 - 10/2017
1Radiotherapy
06/2021
1Intraperitoneal Injections
01/2017